✦ LIBER ✦

Novel Combination Therapies for the Treatment of Relapsed/Refractory Multiple Myeloma: Current Phase I/II Combinations

✍ Scribed by Richardson, Paul; Laubach, Jacob; Schlossman, Robert; Ghobrial, Irene; Mitsiades, Constantine; Hideshima, Teru; Chauhan, Dharminder; Raje, Noopur; Munshi, Nikhil C.; Anderson, Kenneth C.

Book ID: 119936175
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 110 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2009.s.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial assessing bendamustine

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma

✍ Berenson, James R.; Yellin, Ori; Bessudo, Alberto; Boccia, Ralph V.; Noga, Steph 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Phase I/II Trial Assessing Bortezomib an

Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

✍ Berenson, J. R. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 103 KB

Emerging therapies for the treatment of

Emerging therapies for the treatment of relapsed or refractory multiple myeloma

✍ Meletios A. Dimopoulos; Jesus F. San-Miguel; Kenneth C. Anderson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Phase I Trial of Vorinostat Combined Wit

Phase I Trial of Vorinostat Combined With Bortezomib for the Treatment of Relapsing and/or Refractory Multiple Myeloma

✍ Donna M. Weber; Thorsten Graef; Mohamad Hussein; Ronald M. Sobecks; Gary J. Schi 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 279 KB

Combined thalidomide and cyclophosphamid

Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study

✍ Sjoerd Hovenga; Simon M. G. J. Daenen; Joost T. M. de Wolf; Gustaaf W. van Imhof 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 118 KB

A systematic review of phase II trials o

A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma

✍ Marie Von Lilienfeld-Toal; Corinna Hahn-Ast; Kerstin Furkert; Florian Hoffmann; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB